List view / Grid view

Vertex Pharmaceuticals



Moderna discuss mRNA therapeutics in cystic fibrosis

22 July 2016 | By Victoria White, Digital Content Producer

Drug Target Review recently caught up with Lorence Kim, Chief Financial Officer of Moderna, to find out more about the company‘s collaboration with Vertex and using mRNA therapeutics to treat patients with cystic fibrosis...